Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy

Exclusion Criteria

• •Patients with implants in the chest region that contain metal or conductive materials (e.g., metal implants, rods, or plates) which the Sponsor considers will interfere with the Calypso System's electromagnetic localization (note that the Sponsor will review a patient's implanted metal on a case by case basis).
• •Patients with active implanted devices, such as pacemakers, defibrillators, and drug infusion pumps since the effect of the Calypso System operation on these devices is unknown.
• •Patients with active infections.
• •Patients with bronchiectasis in the lobe of the intended implantation sites.
• •Patients with a history of hypersensitivity to nickel.
• •Patients whose lung tumors are being monitored with MR imaging (MR imaging of the anchored transponders is safe but yields an image artifact around the anchored transponders).
• •Patients with any other medical condition or laboratory value that would, at the discretion of the investigator, preclude the patient from participation in this clinical study.
• •Patients enrolled in any other clinical studies the investigator believes to be in conflict with this investigation.